Luo et al. [102] showed that treatments with epigallocatechin gallate in combination with paclitaxel increased apoptosis in a mouse model of breast cancer compared to the use of either anticancer agent alone, thanks to the activation of JNK (Jun N-terminal kinases). Here, MAPK8 is linked to breast cancer.